α1B-Adrenoceptors mediate adrenergically-induced renal vasoconstrictions in rats with renal impairment

Acta Pharmacologica Sinica

Volumn 29, Issue 2, 2008, Pages 193-203

  Khan, Md Abdul Hye ^a   Sattar, Munavvar Abdul ^a   Abdullah, Nor Azizan ^b   Johns, Edward James ^c  

^a SCHOOL OF PHARMACEUTICAL SCIENCES   (Malaysia)

^b UNIVERSITY OF MALAYA   (Malaysia)

^c UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

1B adrenoceptor; Chloroethylclonidine; Rats; Renal resistance vessels

Indexed keywords

ALPHA 1B ADRENERGIC RECEPTOR; CISPLATIN; STREPTOZOCIN; ADRENERGIC RECEPTOR ALPHA(1B); ALPHA 1 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CHLOROETHYLCLONIDINE; CLONIDINE; DRUG DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; HEMODYNAMICS; HYPERGLYCEMIA; KIDNEY ARTERY VASOCONSTRICTION; KIDNEY BLOOD FLOW; KIDNEY DYSFUNCTION; KIDNEY FAILURE; KIDNEY FUNCTION; MALE; NONHUMAN; PATHOPHYSIOLOGY; PHYSIOLOGY; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; STIMULUS RESPONSE; STREPTOZOCIN DIABETES; VASOCONSTRICTION; WISTAR KYOTO RAT; ADRENERGIC SYSTEM; ANIMAL; DRUG EFFECT; IN VITRO STUDY; KIDNEY CIRCULATION; KIDNEY DISEASE; MUSCLE TONE;

ADRENERGIC BETA-AGONISTS; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; CLONIDINE; DIABETIC NEPHROPATHIES; KIDNEY DISEASES; MALE; MUSCLE TONUS; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RECEPTORS, ADRENERGIC, ALPHA-1; RENAL CIRCULATION; SYMPATHETIC NERVOUS SYSTEM; VASOCONSTRICTION;

EID: 38749137418     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2008.00727.x     Document Type: Article

References (44)

1. 2-adrenergic receptors in spontaneously hypertensive rats. Hypertension 1987 9 : 41 81.
2. Sattar MA, Johns EJ. Evidence for an alpha 1-adrenoceptor subtypes mediating adrenergic vasoconstriction in Wistar normotensive and stroke prone hypertensive rats. J Cardiovasc Pharmacol 1994 23 : 232 9.
3. Yang M, Reese J, Cotecchia S, Michel MC. Murine alpha1-adrenoceptor subtypes. I. Radioligand binding studies. J Pharmacol Exp Ther 1998 286 : 841 7.
4. 1-adrenoceptors: functions and phosphorylation. Eur J Pharmacol 2000 389 : 1 12.
5. Guimaraes S, Moura D. Vascular adrenoceptors: an update. Pharmacol Rev 2001 53 : 319 56.
6. 1- adrenoceptors mediating vasoconstriction to noradrenaline and nerve stimulation in the isolated perfused mesentery of rat. Br J Pharmacol 1995 114 : 531 6.
7. 1- adrenoceptor subtypes in rat renal resistance vessels: in vivo and in vitro studies. Am J Physiol 2000 278 : F138 47.
8. Hirasawa A, Sugawara T, Awaji T, Tsumaya K, Ito H, Tsujimoto G. Subtype-specific differences in subcellular localization of alpha1- adrenoceptors: chlorethylclonidine preferentially alkylates the accessible cell surface alpha1-adrenoceptors irrespective of the subtype. Mol Pharmacol 1997 52 : 764 70.
9. Walsh M P. Regulation of vascular smooth muscle tone. Can J Physiol Pharmacol 1994 72 : 919 36.
10. Abdul Sattar M, Johns EJ. Alpha 1-adrenoceptor subtypes mediating adrenergic vasoconstriction in kidney, one-clip Goldblatt and deoxycorticosterone aceta te-salt hypertensive rats. J Cardiovasc Pharmacol 1994 24 : 420 8.
11. Yatsu T, Aoki M, Inagaki O. Preventive effect of zelandopam, a dopamine D1 receptor agonist, on cisplatin-induced acute renal failure in rats. Eur J Pharmacol 2003 461 : 191 5.
12. 1A-adrenoceptors mediate contraction of rat renal artery. Eur J Pharmacol 1997 322 : 225 7.
13. 1A-adrenoceptors in contraction of rat masentric artery. Vascular Pharmacol 2003 40 : 91 6.
14. Armenia A, Munavvar AS, Abdullah NA, Helmi A, Johns EJ. The contribution of adrenoceptor subtypes in the renal vasculature of diabetic spontaneously hypertensive rats. Br J Pharmacol 2004 142 : 719 26.
15. Jahnichen S, Eltze M, Pertz HH. Evidence that alpha (1B)-adrenoceptors are involved in noradrenaline-induced contractions of rat tail artery. Eur J Pharmacol 2004 488 : 157 67.
16. 1-adrenoceptor subtypes involved in vasoconstrictor responses to exogenous and neurally released in rat femoral resistance arteries. Br J Pharmacol 2004 141 : 915 24.
17. 1-adrenoceptor subtype mediating vasoconstriction in the kidney of the rat. Eur J Pharmacol 2007 569 : 110 8.
18. 1-adrenoceptor subtypes in the cardiac failure in spontaneously hypertensive rats. J Basic Applied Sci 2006 2 : 59 69.
19. Stassen FR, Willemsen MJ, Janssen GM, DeMey JG. Alpha 1-adrenoceptor subtypes in rat aorta and mesenteric small arteries are preserved during left ventricular dysfunction post-myocar-dial infarction. Cardiovasc Res 1997 33 : 706 13.
20. Kang DG, Lee AS, Mun YJ, Woo WH, Kim YC, Sohn EJ, et al. Butein ameliorates renal concentrating ability in cisplatin-induced acute renal failure in rats. Biol Pharm Bull 2004 27 : 366 70.
21. Yatsu T, Aoki M, Inagaki O. Preventive effect of zelandopam, a dopamine D1 receptor agonist, on cisplatin-induced acute renal failure in rats. Eur J Pharmacol 2003 461 : 191 5.
22. Shimeda Y, Hirotani Y, Akimoto Y, Shindou K, Ijiri Y, Nishihori T, et al. Protective effects of capsaicin against cisplatin-induced nephrotoxicity in rats. Biol Pharm Bull 2005 28 : 1635 8.
23. Saad SY, Al-Rikabi AC. Protection effects of taurine supplementation against cisplatin-induced nephrotoxicity in rats. Chemotherapy 2002 48 : 42 8.
24. Yin XX, Zhang YD, Shen JP, Wu HW, Zhu X, Li LM, et al. Protective effects of bendazac lysine on early experimental diabetic nephropathy in rats. Acta Pharmacol Sin 2005 26 : 721 8.
25. Saad SY, Arafah MM, Najjar TA. Effects of mycophenolate mofetil on cisplatin-induced renal dysfunction in rats. Cancer Chemother Pharmacol 2007 59 : 455 60.
26. Cooper ME, Allen TJ, Jerums G, Doyle AE. Accelerated progression of diabetic nephropathy in the spontaneously hypertensive streptozotocin diabetic rat. Clin Exp Pharmacol Physiol 1986 13 : 655 62.
27. Usui H, Shikata K, Matsuda M, Okada S, Ogawa D, Yamashita T, et al. HMG-CoA reductase inhibitor ameliorates diabetic nephropathy by its pleiotropic effects in rats. Nephrol Dial Transplant 2003 18 : 265 72.
28. Yin X, Zhang Y, Wu H, Zhu X, Zheng X, Jiang S, et al. Protective effects of Astragalus saponin I on early stage of diabetic nephropathyin rats. J Pharmacol Sci 2004 95 : 256 66.
29. Cooper ME. Interaction of metabolic and haemodynamic factors in mediating experimental diabetic nephropathy. Diabetologia 2001 44 : 1957 72.
30. Nakano R, Kurosaki E, Shimaya A, Kajikawa S, Shibasaki M. YM440, a novel hypoglycemic agent, protects against nephropathy in Zucker fatty rats via plasma triglyceride reduction. Eur J Pharmacol 2006 549 : 185 91.
31. Cruzado JM, Lloberas N, Torras J, Riera M, Fillat C, Herrero-Fresneda I, et al. Regression of advanced diabetic nephropathy by hepatocyte growth factor gene therapy in rats. Diabetes 2004 53 : 1119 27.
32. Ibarra M, Pardo JP, López-Guerrero JJ, Villalobos-Molina R. Differential response to chloroethylclonidine in blood vessels of normotensive and spontaneously hypertensive rats: role of alpha 1D- and alpha 1A-adrenoceptors in contraction. Br J Pharmacol 2000 129 : 653 60.
33. Perez DM, Piascik MT, Malik N, Gaivin R, Graham RM. Cloning, expression, and tissue distribution of the rat homolog of the bovine alpha 1C-adrenergic receptor provide evidence for its classification as the alpha 1A subtype. Mol Pharmacol 1994 46 : 823 31.
34. Jahnichen S, Eltze M, Pertz HH. Evidence that alpha (1B)-adrenoceptors are involved in noradrenaline-induced contractions of rat tail artery. Eur J Pharmacol 2004 488 : 157 67.
35. 1- adrenoceptors mediating vasoconstriction to noradrenaline and nerve stimulation in the isolated perfused mesentery of rat. Br J Pharmacol 1995 114 : 531 6.
36. Leclerc G, Rouot B, Schwartz J, Velly J, Wermuth CG. Studies on some para-substituted clonidine derivatives that exhibit an alpha-adrenoceptor stimulant activity. Br J Pharmacol 1980 71 : 5 9.
37. Docherty JR, O'Rourke M. The α-adrenoceptor-mediated actions of chloroethylclonidine. Gen Pharmacol 1997 28 : 97 101.
38. Hirasawa A, Sugawara T, Awaji T, Tsumaya K, Ito H, Tsujimoto G. Subtype-specific differences in subcellular localization of alpha1- adrenoceptors: chlorethylclonidine preferentially alkylates the accessible cell surface alpha1-adrenoceptors irrespective of the subtype. Mol Pharmacol 1997 52 : 764 70.
39. Yang M, Reese J, Cotecchia S, Michel MC. Murine alpha1-adrenoceptor subtypes. I. Radioligand binding studies. J Pharmacol Exp Ther 1998 286 : 841 7.
40. 1A-adrenoceptors, protein kinase C, and calcium influx. Arch Med Res 2001 32 : 258 62.
41. 1-adrenoceptors: func-tions and phosphorylation. Eur J Pharmacol 2000 389 : 1 12.
42. Li Z, Silver WP, Koman LA, Strandhoy JW, Rosencrance E, Gordon S, et al. Role of alpha-1 adrenoceptor subtypes mediating constriction of the rabbit ear thermoregulatory microvasculature. J Orthop Res 2000 18 : 156 63.
43. Kahan T. Prejunctional adrenergic receptors and sympathetic neurotransmission: studies in canine skeletal muscle vasculature in situ. Acta Physiol Scand 1987 560 : 1 38.
44. 1-adrenoceptor. Eur J Pharmacol 1991 199 : 279 89.